drugset / Trial / NCT01137565

Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma

NCT01137565 ↗

Phase 1 Completed 23 enrolled Amgen
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to study the safety and tolerability in adolescent and adult subjects with intermittent or mild to moderate persistent asthma.

Timeline

Start
2010-06
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject VIDUPIPRANT Small molecule — —

Indications